Trials / Withdrawn
WithdrawnNCT02408042
Study of Pembrolizumab With Chemotherapy in Patients With Advanced Lymphoma (PembroHeme)
A Phase Ib/II Study of Pembrolizumab With Chemotherapy in Patients With Advanced Lymphoma (PembroHeme)
- Status
- Withdrawn
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Western Regional Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To determine the recommended phase 2 dose of chemotherapy in combination with Pembrolizumab in subjects with advanced lymphoma and determine the complete response rate.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Pembrolizumab | |
| DRUG | Etoposide | |
| DRUG | Ifosfamide | |
| DRUG | Mesna | |
| DRUG | Carboplatin | |
| DRUG | Brentuximab vedotin | |
| DRUG | Rituximab |
Timeline
- Start date
- 2015-04-01
- Primary completion
- 2015-11-01
- Completion
- 2015-11-01
- First posted
- 2015-04-03
- Last updated
- 2017-06-27
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02408042. Inclusion in this directory is not an endorsement.